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Inﬂammatory response is considered the most important period that regulates the entire healing process. Conjugated linoleic
acid (CLA), a class of linoleic acid positional and geometric isomers, is well known for its antioxidant and anti-inﬂammatory
properties.WehypothesizedthatdietaryCLAsupplementationacceleratescutaneouswoundhealingbyregulatingantioxidantand
anti-inﬂammatory functions. To investigate wound closure rates and inﬂammatory responses, we used a full-thickness excisional
wound model after 2-week treatments with control, 0.5%, or 1% CLA-supplemented diet. Mice fed dietary CLA supplementation
had reduced levels of oxidative stress and inﬂammatory markers. Moreover, the wound closure rate was improved signiﬁcantly in
mice fed a 1% CLA-supplemented diet during early stage of wound healing (inﬂammatory stage). We conclude that dietary CLA
supplementation enhances the early stage of cutaneous wound healing as a result of modulating oxidative stress and inﬂammatory
responses.
1.Introduction
Wound healing is an essential procedure that helps maintain
homeostasis and integrate tissue injured by physical, chemi-
cal, bacterial, or viral insults [1–3]. Generally, there are three
majorstagesofwoundhealingthatoverlapintimeandspace:
inﬂammation, proliferation, and remodeling [4]. Because
it is involved in producing growth factors and cytokines
that coordinate the cell and tissue movements necessary for
repair, the inﬂammatory response is considered the most
importantperiodthatregulatestheentirehealingprocess[5–
7]. The initial event of the inﬂammatory stage during wound
healing is the inﬁltration of neutrophils and macrophages
into the wound site to attack contaminating bacteria and
to phagocytose cellular debris resulting in the production
of reactive oxygen species (ROS). Furthermore, neutrophils
and macrophages are both major sources and targets of
proinﬂammatory cytokines such as IL-1α,I L - 1 β,I L - 6 ,a n d
TNF-α that have been shown to be crucial mediators during
cutaneous inﬂammatory processes [4, 5]. For example, IL-1β
and TNF-α, primary proinﬂammatory cytokines, promote
nuclear factor κB( N F κB) activation and ROS production
in inﬂammatory cells [8–10]. NFκB is a redox-sensitive
transcription factor that acts as a central protein regulating
the transcription of many inﬂammatory mediators including
cyclooxygenase (COX)-2, a rate-limiting enzyme in the
biosynthesis of prostaglandins during inﬂammation and
immune response. Because of its essential role in controlling
inﬂammatory responses, regulation of NFκBa c t i v a t i o nb y
the oxidative stress present during the early inﬂammatory
cascade may be advantageous in the treatment of wounds.
Cells in injured and inﬂamed tissues are able to pro-
tect themselves with a well-equipped array of antioxidant
enzymes, such as glutathione peroxidase (GPX), catalase,
superoxide dismutases (SODs), and heme oxygenases (HO).
SODs dismutate superoxide radical anions to H2O2 and
water. A previous study has shown that mRNA levels of
CuZnSOD and MnSOD were upregulated in the early
inﬂammatory stage of cutaneous wound healing [11]. HO-
1, the inducible isoform of HO, shows protection against
ROS as well. In mouse full-thickness excisional wounds, the
mRNA and protein levels of HO-1 increased after wounding
and subsequently declined until the wound was healed [11],
which proposes a role of HO-1 in a protective function
through reduction of inﬂammation [12].2 Mediators of Inﬂammation
Despite the remarkable signiﬁcance of inﬂammation,
most studies have focused on the later stage of wound heal-
ing, the remodeling stage, especially in collagen formation
and maturation [13]. Our group previously demonstrated
that N-acetylcysteine and zinc known as antioxidant nutri-
ents played important role in regulation of wound healing
rate and inﬂammatory response during wound healing
procedure [1, 14]. However, except these two antioxidant
nutrients, little is known on the molecular mechanism that
controls the wound healing rate.
Conjugated linoleic acid (CLA) refers to a class of the
essential fatty acid linoleic acid positional and geometric
isomers, marked by conjugated double bond [15]. CLA was
found naturally in meat and dairy products from cows
and sheep due to the process of bacterial biohydrogenation
of linoleic acid (LA) in the rumen [16]. Interest in CLA
came ﬁrst from its anticarcinogenic action [17] and now
there is a growing literature showing the beneﬁcial eﬀects
of CLA, such as antiadipogenic [15, 18], antiatherogenic
[19, 20], antidiabetogenic [21, 22], anti-inﬂammatory [23–
26], and antioxidant properties [27–29]. It was suggested
that CLA is eﬀective in improving skin disorders in animals
[30]. In addition, Hwang et al. have reported that CLA
inhibited NFκB-driven COX-2 protein expression in mouse
skin carcinogenesis [31]. However, the eﬀect of CLA on
cutaneous wound healing is poorly documented.
We hypothesized that dietary CLA supplementation
promotes cutaneous wound healing through modulation
of inﬂammatory responses including NFκB activation. In
particular, we used a cutaneous full-thickness excisional
wound model to examine the eﬀects of dietary CLA supple-
mentation on the rate of wound closure, and the temporal
expression levels of pIκBα,C O X - 2 ,C u Z n S O D ,M n S O D ,a n d
HO-1 protein levels during the early inﬂammatory stage of
cutaneous wound healing.
2.MaterialsandMethods
2.1. Animals and Diets. Female CrljBgi:CD-1 (ICR) mice
(4wks old) were purchased from Orient Bio Inc. (Gyeonggi-
do, South Korea) and lodged in individual plastic cages
at temperature- and humidity-controlled room (12-hr
light:dark cycle) with allowed access to distilled water and
food. Body weights and food intake were measured every
three days and every day, respectively. Mice were acclimated
for 7 days (d) before starting dietary treatments. They were
fed a modiﬁed AIN-93G rodent diet supplemented with
0 (control), 0.5%, or 1% CLA for 2wks (Han Live R&D,
Gyeonggi-do, South Korea) (Tables 1 and 2). All mice were
used in accordance with animal protocols approved by the
Kyung Hee University Institutional Animal Care and Use
Committee.
2.2. Wound Biopsy. Mice were anesthetized with isoﬂurane
and the back of the mouse was shaved using an electronic
clipper and sterilized using an alcohol swab. The wound
biopsy model used in this experiment has been previously
described [32]. The skin was then nipped and bent, and the
Table 1: Diet composition of experimental group.
Experimental diets∗
Control 0.5% CLA 1% CLA
g/100g
Casein 20 20 20
Cornstarch 39.7486 39.7486 39.7486
Dyetrose 13.2 13.2 13.2
Sucrose 10 10 10
Cellulose 5 5 5
Corn Oil 7 6.388 5.776
CLA — 0.612 1.224
t-Butylhydroquinone 0.0014 0.0014 0.0014
Salt Mix #210025 3.5 3.5 3.5
Vitamin Mix #310025 1.0 1.0 1.0
L-Cystine 0.3 0.3 0.3
Choline Bitartarate 0.25 0.25 0.25
Total 100 100 100
∗Control, no CLA isomers; 0.5% CLA, 0.5g CLA/100g diet; 1% CLA, 1g
CLA/100g diet.
Table 2: Major fatty acid composition in diets.
Fatty acids Composition %
cis-9, trans-11 CLA 37.99
trans-10, cis-12 CLA 39.09
cis-9, cis-11 CLA 3.36
trans-9, trans-11 CLA 1.22
Total CLA 81.67
full-thickness excisional wounds were made on the bent skin
using a sterile biopsy punch (4mm diameter, Kai medical,
Gifu City, Japan). Two round shape wounds on the dorsum,
below the shoulder blades of each mouse were made to avoid
self-licking.
2.3. Harvesting. Mice were sacriﬁced with an overdose of
ethyl ether to gather tissue samples at the wound site. Each
wound site at 0, 24, 48, and 72 hours (hr) after wounding
and at end point was harvested by a cutting area that covered
the entire wound site.
2.4. Malondialdehyde Measurement. Levels of malondialde-
hyde (MDA) were measured as a marker of lipid perox-
idation [33, 34]. Ten percent (weight/volume) liver tis-
sues were homogenized with 0.15M KCl buﬀer. 0.2ml
of tissue homogenate, 0.2ml sodium dodecyl sulphate,
8.1% (weight/volume), and 3ml 20% acetic acid-0.8% TBA
mixture (1:1, by volume) were added, to reach the volume
of 4ml. Samples were then blended, warmed for 60 minutes
(min), maintained at 95
◦C, and then cooled under tap
water immediately. To each tube, 1ml distilled water and
5ml mixture of n-butanol and pyridine (15:1, by volume)
were supplemented and shaken vigorously and centrifuged
at 4,000rpm for 10min. The upper layer was aspiratedMediators of Inﬂammation 3
out and absorbancy was measured at 532nm using 1,1,3,3-
tetramethoxypropane as an external criterion.
2.5. Measurement of Wound Closure. Wounds from each
mouse were photographed digitally every day, beginning
on the day of wounding (d 0) with a criterion spot equal
to the initial wound part placed beside the wound. The
quantiﬁcation of wound closure used in this experiment was
previously described [35] .T h er a t eo fw o u n dc l o s u r ew a s
demonstrated as the ratio of the wound size (each day after
wounding) compared with the initial wound size. A smaller
wound ratio indicates faster wound closure.
2.6. Preparation of Homogenized Skin Tissue Proteins and
Western Blot. Skintissuesfromthewoundsiteswerehomog-
enized in lysis buﬀer (20mM Tris-HCl (Sigma, St. Louis,
MO, USA), 150mM NaCl2 (Duksan, Gyeonggi-do, South
Korea), pH7.5, 1% NP40 (Sigma), 0.5% Na-deoxycholate
stock (Sigma), 1mM EDTA (Duksan), and 0.1% sodium
dodecyl sulfate (Sigma)) as previously described by our
group [36]. The homogenates were incubated on ice for
20min and centrifuged at 14,000rpm for 30mins. The
supernatants were stored at −80
◦C until additional process-
ing.
For Western blot analysis, samples (60μg protein,
determined using BioRad protein assay; BioRad, Hercules,
CA, USA) were separated on 10% SDS-PAGE gels and
electrotransferred onto PVDF (polyvinylidene ﬂuoride)
membranes. After blocking in 5% nonfat milk in PBS-
Tween 20, the membranes were incubated with speciﬁc
monoclonal and polyclonal antibodies against phospho-
rylated IκBα (pIκBα) (Santa Cruz Biotechnology, Santa
Cruz CA, USA, 1:200), COX-2 (Transduction Laboratories,
Lexington KY, USA, 1:250), HO-1 (Stressgen, Victoria BC,
Canada, 1:2000), CuZnSOD (Santa Cruz Biotechnology,
1:500), MnSOD (Stressgen, 1:5000), and β-actin (Santa
Cruz Biotechnology, 1:200). Horseradish peroxidase con-
jugated antibody (Santa Cruz Biotechnology) was used as
secondary antibody and bound antibodies were visualized
by enhanced chemiluminescence (ECL Western Blotting
Substrate, Pierce), captured on X-ray ﬁlm (Agfa-Gevaert
N.V.), and band densities were quantiﬁed using NIH image
software.
2.7. Statistical Analysis. A l lv a l u e sa r ee x p r e s s e da sm e a n s±
SEM. Data were analyzed by 1-way ANOVA, and then
diﬀerences among means were analyzed using Duncan’s test.
The relationships between body weight gain and wound size
were evaluated by Pearson’s correlation coeﬃcients. For all
tests, diﬀerences were considered signiﬁcant at P<. 05.
3. Results
3.1. Eﬀect of Dietary CLA Supplementation on Body Weight
and Food Intake. Dietary CLA supplementation signiﬁcantly
reduced the body weights gain in mice throughout the
experimental periods compared to a control diet (Figure 1).
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Figure 1: Changes in body weight in mice fed diets containing 0
(control), 0.5%, or 1% CLA for 2 weeks. Values are means ± SEM;
N = 4 to 6 in each group. Means at a time with a diﬀerent letter are
signiﬁcantly diﬀerent, P<. 05.
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Figure 2: Liver MDA levels in mice fed diets containing 0 (control),
0.5%,or1%CLAfor2weeks.Valuesaremeans±SEM;N = 4to6in
each group. Means with a diﬀerent letter are signiﬁcantly diﬀerent,
P<. 05.
Particularly, body weight gain was lower in the 1% CLA-
supplemented group than the control and 0.5% CLA-
supplemented groups (P<. 05). The food intakes during
the experiments were not signiﬁcantly diﬀerent among the
groups (data not shown).
3.2. Eﬀect of Dietary CLA Supplementation on MDA Levels
of Mouse Liver. Dietary CLA supplementation resulted in a
decrease of liver lipid peroxidation measured as MDA levels
(Figure 2).LiverMDAlevelsweresigniﬁcantlylowerinCLA-
supplemented groups as compared to the controls (about
2.4-to3.7-times,resp.).Nodiﬀerencesbetweenthe0.5%and
the 1% CLA-supplemented groups were noted.4 Mediators of Inﬂammation
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Figure 3: The rate of wound closure in mice fed diets containing 0
(control), 0.5%, or 1% CLA for 2 weeks. The area of the wound of
each time point was relative to the area of the wound on d 0 (set at
1.0). Values are means±SEM; N = 4 to 6 in each group. Means at a
time with a diﬀerent letter are signiﬁcantly diﬀerent, P<. 05.
Table 3: Relationships (Pearson’s correlation coeﬃcients) between
body weight gain and wound size.
Wound size
d 1 (24hr) d 2 (48hr) d 3 (72hr)
Body weight gain .580
∗ .548
∗ .552
∗
∗P<. 05.
3.3. Eﬀect of Dietary CLA Supplementation on Wound Clo-
sure Rate. The rate of wound closure in the 1% CLA-
supplemented group was signiﬁcantly faster than those of
the control and the 0.5% CLA-supplemented groups during
the early stage of wound healing (Figure 3). Although not
signiﬁcant, the 0.5% CLA-supplemented groups showed a
fasterwoundclosureratethanthecontrol,suggestingadose-
dependent eﬀect of CLA.
3.4. Eﬀect of Dietary CLA Supplementation on Relationships
between Body Weight Gain and Early Wound Size. We
performedstatisticalanalysistoidentifycorrelationsbetween
body weight gain and early wound size as shown in Table 3.
Body weight was positively correlated to early wound size
(P<. 05).
3.5. Eﬀect of Dietary CLA Supplementation on pIκBα Expres-
sion Levels. During wound healing, pIκBα protein level
increased in all groups. The expression levels of pIκBα in
the 1% dietary CLA supplemented group were signiﬁcantly
reduced starting at 48hr after wounding compared to the
other groups (Figure 4).
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Figure 4: pIκBα protein expression in cutaneous wounds of mice
fed diets containing 0 (control), 0.5%, or 1% CLA for 2 weeks.
(a) Quantiﬁed pIκBα protein expression levels determined by
densitometry. Values are mean ± SEM; N = 4t o6i ne a c hg r o u p .
Means at a time with a diﬀerent letter are signiﬁcantly diﬀerent,
P<. 05. (b) 0; 0hr, 24; 24hr, 48; 48hr, 72; 72hr after wounding,
end (wound is completely closed).
3.6. Eﬀect of Dietary CLA Supplementation on COX-2 Expres-
sion in Mouse Skin. As shown in Figure 5, the expression of
COX-2 protein was barely detectable at baseline (0hr), and
it was induced in all groups after wounding. The expression
levels of COX-2 at 24hr after wounding were remarkably
reduced in the dietary CLA-supplemented mice (P<. 05)
and returned to the steady levels in all groups at the end
point.
3.7. Eﬀect of Dietary CLA Supplementation on HO-1 Expres-
sion in Mouse Skin. Signiﬁcant decreases in HO-1 protein
levels in the dietary CLA-supplemented groups were shown
at all time points compared with the control group during
wound healing (Figure 6).
3.8. Eﬀect of Dietary CLA Supplementation on CuZnSOD
Expression in Mouse Skin. Expression levels of CuZnSOD
proteininthecontrolgroupweresigniﬁcantlyhigherat24hr
and48hrafterwounding(2folds)ascomparedwiththosein
the dietary CLA-supplemented groups (Figure 7).Mediators of Inﬂammation 5
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Figure 5: COX-2 protein expression in cutaneous wounds of mice
fed diets containing 0 (control), 0.5%, or 1% CLA for 2 weeks.
(a) Quantiﬁed COX-2 protein expression levels determined by
densitometry. Values are mean ± SEM; N = 4t o6i ne a c hg r o u p .
Means at a time with a diﬀerent letter are signiﬁcantly diﬀerent,
P<. 05. (b) 0; 0hr, 24; 24hr, 48; 48hr, 72; 72hr after wounding,
end (wound is completely closed).
3.9. Eﬀect of Dietary CLA Supplementation on MnSOD
Expression in Mouse Skin. Like CuZnSOD, we also detected
a signiﬁcant increase in MnSOD protein in the controls
compared to the dietary CLA-supplemented groups at 24hr
and 48hr after wounding (Figure 8). MnSOD protein levels
in the controls were clearly increased after wounding, while
no changes were noted in the dietary CLA-supplemented
groups.
4. Discussion
In these experiments, we investigated the eﬀects of dietary
CLA supplementation on molecular events in the early
inﬂammatory stage of cutaneous wound healing using an
in vivo model. Our data demonstrated that dietary CLA
supplementation decreased weight gain, reduced the levels
of both inﬂammatory and oxidative stress markers at wound
sites, and accelerated the wound closure rate.
W ef o u n dw e i g h tl o s se ﬀects of dietary CLA supple-
mentation in mice as conﬁrmed by previous studies. The
eﬀectsofCLAinregulatingbodyweighthavebeensupported
by several animal studies [15, 18]. Reduction in body
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Figure 6: HO-1 protein expression in cutaneous wounds of
mice fed diets containing 0 (control), 0.5%, or 1% CLA for 2
weeks. (a) Quantiﬁed HO-1 protein expression level determined by
densitometry. Values are mean ± SEM; N = 4t o6i ne a c hg r o u p .
Means at a time with a diﬀerent letter are signiﬁcantly diﬀerent,
P<. 05. (b) 0; 0hr, 24; 24hr, 48; 48hr, 72; 72hr after wounding,
end (wound is completely closed).
weight seems to be mainly due to the decreased adipose
deposition, as a consequence of a gain in lean mass or
protein substances. Moreover, the present study supported
a correlation between obesity and increased morbidity and
mortality after traumatic injury. Previous studies showed
that obese trauma patients have a higher likelihood to
experience postoperative infectious complications, incidence
of multiple organ dysfunction, and longer hospitalization
when compared with nonobese patients after acute injury
[37–39]. Our date are in accordance with the above-
mentioned reports since a lower body weight gain by dietary
CLA supplementation improved the wound closure rate.
Previous studies showed that dietary CLA enhanced
oxidative stability of liver [40, 41], which suggested that
dietary CLA supplementation increases the ability of protec-
tion to oxidative stress and scavenging free radicals and this
can explain the decreased MDA levels, the marker of lipid
peroxidation, observed in liver of dietary CLA supplemented
mice (Figure 2).
To understand part of the molecular mechanisms
through which dietary CLA supplementation modiﬁes the
rate of the wound closure, we investigated NFκBa c t i v a t i o n6 Mediators of Inﬂammation
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Figure 7: CuZnSOD protein expression in cutaneous wounds of
mice fed diets containing 0 (control), 0.5%, or 1% CLA for 2 weeks.
(a) Quantiﬁed CuZnSOD protein expression level determined by
densitometry. Values are mean ± SEM; N = 4t o6i ne a c hg r o u p .
Means at a time with a diﬀerent letter are signiﬁcantly diﬀerent, P<
.05. (b) 0; 0hr, 24; 24hr, 48; 48hr, 72; 72hr after wounding, end
(wound is completely closed).
through the expression of pIκBα.N F κB is sequestered in
the cytoplasm of unstimulated cells bound to the inhibitory
protein, IκB[ 42]. Exposure of cells to various stimuli such
as ROS, proinﬂammatory cytokines, UV light, or bacterial
endotoxins results in NFκB activation and then IκBi s
phosphorylated and degraded, promoting the translocation
of NFκB to the nucleus where it controls the expression of
speciﬁc cellular genes associated with host inﬂammatory and
immune response [42]. Our data demonstrated that pIκBα
protein levels generally were downregulated in mice fed
dietary CLA supplementation than in mice fed the control
diet (Figure 4). Furthermore, the accelerated rate of wound
closureinmicefedthe1%CLAsupplementeddietparalleled
the decrease in pIκBα protein levels. It is well recognized that
the activationof NFκB is redox sensitive and can be inhibited
by antioxidants [42]. It was suggested that CLA is an inﬂuen-
tial antioxidant that shows free radical scavenging activities
[28]. Previous studies represented that CLA decreased NFκB
activation [43], conﬁrming our data suggesting that dietary
CLA supplementation may accelerate wound healing as a
result of down-regulated NFκB activation.
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Figure 8: MnSOD protein expression in cutaneous wounds of mice
fed diets containing 0 (control), 0.5%, or 1% CLA for 2 weeks.
(a) Quantiﬁed MnSOD protein expression level determined by
densitometry. Values are mean ± SEM; N = 4t o6i ne a c hg r o u p .
Means at a time with a diﬀerent letter are signiﬁcantly diﬀerent,
P<. 05. (b) 0; 0hr, 24; 24hr, 48; 48hr, 72; 72hr after wounding,
end (wound is completely closed).
To investigate the eﬀect of dietary CLA supplementation
on NFκB activation and following events during the early
inﬂammatory stage, protein levels of the inﬂammatory
mediator COX-2, a target gene of NFκB activation, were
examined at diﬀerent time points. The expression of COX-
2 is scarcely detectable under normal physiological states.
On the contrary, it can be induced by proinﬂammatory
cytokines, bacterial endotoxins, growth factors, and phorbol
estersthroughNFκBacti vati o n[44].Becauseofitsbiological
role in chronic inﬂammatory diseases [45], it is possible
that down-regulated expression levels of COX-2 protein
may accelerate the wound healing procedure by reducing
inﬂammatory response. Similar to previous studies [31],
we found that dietary CLA supplementation downregu-
lated COX-2 expression. Therefore, this result suggests that
dietary CLA supplementation may apply its beneﬁcial eﬀect
via modiﬁcation in the expression levels of inﬂammatory
mediators such as COX-2 during wound healing. Because
the activation of NFκB is redox sensitive, the antioxidant
eﬀect of CLA blocks NFκB activation and downregulates its
downstream target, COX-2.
Duringtheinﬂammatoryphaseofwoundhealing,innate
immune cells that are present in the wound produce andMediators of Inﬂammation 7
secrete large amounts of ROS, which are of necessity to
protect the organism against invading bacteria [11]. If ROS
are produced in excessive amounts or the detoxiﬁcation of
ROS is insuﬃcient, oxidative stress occurs. HO-1 is involved
in the cell response against oxidative injury. The present
results showed that the levels of HO-1 protein in mice fed
dietaryCLAsupplementationswerelowerthanthoseinmice
fed the control diet. In addition, the levels of CuZnSOD and
MnSOD protein in mice fed the dietary CLA supplementa-
tion were lower than those in mice fed the control diet. This
can suggest that ROS levels be reduced in mice fed dietary
CLA compared to the control and this could be the ability
of CLA to quench the ROS generated by innate immune
cells [28]. The controlled protein expression of several ROS-
scavenging enzymes such as HO-1, CuZnSOD, and MnSOD
that we observed after skin injury seems to be in contrast
to ﬁndings of other researchers [46], who found enhanced
expression of ROS-detoxifying enzymes at the wound site
resulting in improvement of healing by regulating the levels
of ROS. Oxidative stress and ROS detoxifying enzymes
can always represent a double face. The up-regulation of
the enzymes can help wound healing, but from the other
side, it can be the consequences of an increased oxidative
stress. In our previous work [35], we showed that oxidative
stress can slow down the wound healing process and it was
parallel to increased HO-1 levels. Therefore, our result of
lowered protein expression of ROS-detoxifying enzymes in
skin wound healing might be attributed to down-regulated
generationofROSconﬁrmedindecreasedMDAlevelinliver,
possibly by dietary CLA supplementation.
5. Conclusions
Taken together, the results of this study suggest that dietary
CLA supplementation accelerates the early inﬂammatory
response during wound healing. Because of the critical role
of NFκB, which is required for the induction of an inﬂam-
matory mediator COX-2 during inﬂammation, reduced
activation of NFκB may prevent prolonged inﬂammatory
responses by decreased oxidative stress in CLA supplemen-
tation, which is conﬁrmed through HO-1, CuZnSOD, and
MnSOD expression.
In conclusion, the current study demonstrated that CLA
exerts beneﬁcial eﬀects on the early inﬂammatory response
of cutaneous wound healing through the modulation of
inﬂammatory response and oxidative stress. Therefore, the
results may provide critical insight into future nutritional
intervention strategies designed to enhance early wound
healing not only in people with normal body weight but in
overweight or obese people.
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